The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

22 articles for DJ Burdick


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFR.EBI
Genentech
Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitors.EBI
Genentech
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutation.EBI
Genentech
Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.EBI
Genentech
Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor.EBI
Genentech
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.EBI
Genentech
Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling.EBI
Genentech
Cyclic RGD peptide analogues as antiplatelet antithrombotics.EBI
Genentech
N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationship.EBI
Genentech
Structure-based design of thienobenzoxepin inhibitors of PI3-kinase.EBI
Genentech
 
Stereochemistry of the benzodiazepine based Ras farnesyltransferase inhibitorsEBI
TBA
N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moiety.EBI
Genentech
Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains.EBI
Genentech
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-like.EBI
Genentech
GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2).EBI
Genentech
2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's diseaseBDB
H. Lundbeck
Validation of flavonoids as potential dipeptidyl peptidase III inhibitors: Experimental and computational approach.BDB
Josip Juraj Strossmayer University of Osijek
Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor.BDB
Jamia Hamdard (Hamdard University)
Kinase inhibitorsBDB
Allergan
Quinazoline-7-ether compounds and methods of useBDB
Newgen Therapeutics
Kinetic properties and inhibition of the dimeric dUTPase-dUDPase from Campylobacter jejuni.BDB
Instituto De Parastiologia Y Biomedicina "Lopez-Neyra